Activating transcription factor 2 in mesenchymal tumors

Human Pathology

Volumn 45, Issue 2, 2014, Pages 276-284

  Endo, Makoto ^a,b   Su, Le ^a   Nielsen, Torsten O ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Activating transcription factor 2; Immunohistochemistry; Mesenchymal tumor; Transcription factor; Translocation associated sarcoma

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2;

ALVEOLAR SOFT PART SARCOMA; ANGIOSARCOMA; ARTICLE; CHONDROBLASTOMA; CHONDROSARCOMA; CLEAR CELL SARCOMA; CONTROLLED STUDY; CYTOPLASM; DERMATOFIBROSARCOMA PROTUBERANS; DESMOID TUMOR; DESMOPLASTIC SMALL ROUND CELL TUMOR; EMBRYONAL RHABDOMYOSARCOMA; ENCHONDROMA; ENDOMETRIUM SARCOMA; EPITHELIOID SARCOMA; EWING SARCOMA; FASCIITIS; FIBROMA; FIBROMATOSIS; FIBROSARCOMA; FIBROXANTHOMA; GASTROINTESTINAL STROMAL TUMOR; HEMANGIOENDOTHELIOMA; HEPATOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; LIPOMA; LIPOSARCOMA; LYMPHOMA; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MELANOMA; MESENCHYMOMA; MESOTHELIOMA; MYXOSARCOMA; NEPHROBLASTOMA; NERVE TUMOR; NEURILEMOMA; NEUROFIBROMA; OSSIFYING MYOSITIS; OSTEOCHONDROMA; OSTEOSARCOMA; PERIPHERAL NERVE TUMOR; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; RNA INTERFERENCE; SOLITARY FIBROUS TUMOR; SPINDLE CELL SARCOMA; SYNOVIAL SARCOMA; TISSUE MICROARRAY; WESTERN BLOTTING;

ACTIVATING TRANSCRIPTION FACTOR 2; IMMUNOHISTOCHEMISTRY; MESENCHYMAL TUMOR; TRANSCRIPTION FACTOR; TRANSLOCATION-ASSOCIATED SARCOMA;

ACTIVATING TRANSCRIPTION FACTOR 2; CELL NUCLEUS; CYTOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS, CONNECTIVE AND SOFT TISSUE; SARCOMA, SYNOVIAL; TISSUE ARRAY ANALYSIS;

EID: 84892832081     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.09.003     Document Type: Article

References (26)

1. E. Lau, and Z.A. Ronai ATF2 - at the crossroad of nuclear and cytosolic functions J Cell Sci 125 2012 2815 2824
2. N. Riggi, L. Cironi, M.L. Suva, and I. Stamenkovic Sarcomas: genetics, signalling, and cellular origins. Part 1: the fellowship of TET J Pathol 213 2007 4 20
3. L. Su, A.V. Sampaio, and K.B. Jones et al. Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics Cancer Cell 21 2012 333 347
4. P.R. Manna, M.T. Dyson, and D.M. Stocco Role of basic leucine zipper proteins in transcriptional regulation of the steroidogenic acute regulatory protein gene Mol Cell Endocrinol 302 2009 1 11
5. A. Bhoumik, and Z. Ronai ATF2: a transcription factor that elicits oncogenic or tumor suppressor activities Cell Cycle 7 2008 2341 2345
6. A. Nagadoi, K. Nakazawa, and H. Uda et al. Solution structure of the transactivation domain of ATF-2 comprising a zinc finger-like subdomain and a flexible subdomain J Mol Biol 287 1999 593 607
7. P. Lopez-Bergami, E. Lau, and Z. Ronai Emerging roles of ATF2 and the dynamic AP1 network in cancer Nat Rev Cancer 10 2010 65 76
8. A.J. Berger, H.M. Kluger, and N. Li et al. Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival Cancer Res 63 2003 8103 8107
9. M. Gozdecka, and W. Breitwieser The roles of ATF2 (activating transcription factor 2) in tumorigenesis Biochem Soc Trans 40 2012 230 234
10. Z. Ronai, Y.M. Yang, S.Y. Fuchs, V. Adler, M. Sardana, and M. Herlyn ATF2 confers radiation resistance to human melanoma cells Oncogene 16 1998 523 531
11. V.N. Ivanov, and Z. Ronai p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NF-kappaB activity and Fas expression Oncogene 19 2000 3003 3012
12. Y.M. Yang, L.R. Dolan, and Z. Ronai Expression of dominant negative CREB reduces resistance to radiation of human melanoma cells Oncogene 12 1996 2223 2233
13. T.O. Nielsen, F.D. Hsu, and J.X. O'Connell et al. Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology Am J Pathol 163 2003 1449 1456
14. T.L. Ng, A.M. Gown, and T.S. Barry et al. Nuclear beta-catenin in mesenchymal tumors Mod Pathol 18 2005 68 74
15. H. Cheng, J. Dodge, and E. Mehl et al. Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays Hum Pathol 40 2009 1244 1251
16. S.E. Steigen, B. Straume, and D. Turbin et al. Clinicopathologic factors and nuclear morphometry as independent prognosticators in KIT-positive gastrointestinal stromal tumors J Histochem Cytochem 56 2008 139 145
17. M. Pacheco, and T.O. Nielsen Histone deacetylase 1 and 2 in mesenchymal tumors Mod Pathol 25 2012 222 230
18. J. Terry, T. Saito, and S. Subramanian et al. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies Am J Surg Pathol 31 2007 240 246
19. Y. Sun, D.A. Turbin, and K. Ling et al. Type I gamma phosphatidylinositol phosphate kinase modulates invasion and proliferation and its expression correlates with poor prognosis in breast cancer Breast Cancer Res 12 2010 R6
20. A. Kawai, N. Naito, and A. Yoshida et al. Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1 Cancer Lett 204 2004 105 113
21. S. Knippen, T. Loning, V. Muller, C. Schroder, F. Janicke, and K. Milde-Langosch Expression and prognostic value of activating transcription factor 2 (ATF2) and its phosphorylated form in mammary carcinomas Anticancer Res 29 2009 183 189
22. S.Y. Chen, S. Takeuchi, and K. Urabe et al. Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous angiosarcoma and pyogenic granuloma J Cutan Pathol 35 2008 722 730
23. K. Kosemehmetoglu, J.A. Vrana, and A.L. Folpe TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms Mod Pathol 22 2009 872 878
24. A. Jagdis, B.P. Rubin, R.R. Tubbs, M. Pacheco, and T.O. Nielsen Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma Am J Surg Pathol 33 2009 1743 1751
25. T. Knosel, S. Heretsch, and A. Altendorf-Hofmann et al. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases Eur J Cancer 46 2010 1170 1176
26. W.C. Foo, M.W. Cruise, M.R. Wick, and J.L. Hornick Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics Am J Clin Pathol 135 2011 839 844